Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.
Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.
Active, not recruiting · NCT07014280 · Registry updated 2025-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids. | Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Active, not recruiting | Phase 4 | 2025-06-10 | NCT07014280 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kasr El Aini Hospital | 29 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kasr El Ainy University Hospital, faculty of medicine, Cairo university | Cairo | Egypt | 1 |